A Red Mark or Lump Where You Injected Wegovy: Is It Normal?

Week 3 on Wegovy, I pressed the pen against the same soft patch of belly I'd been favoring, counted to 10, pulled it away — and a day later there was a coin-sized bloom of pink sitting right where the needle had gone in. Warm to the touch. And when I rolled my fingertip over it, a small firm lump underneath, like a lentil parked just below the skin.

My first thought was the unhelpful one: something's wrong with me. My second, at 11 p.m., was to open three browser tabs and scare myself thoroughly.

So here's the piece I wish those tabs had handed me, before the panic and the doom-scroll. Most of the time, a red, itchy, slightly lumpy spot where you injected is a local reaction — the skin's small, contained complaint about being poked. On semaglutide it's uncommon, and it usually quiets down on its own within a few days. There's exactly one situation that's a different animal, and I'll draw that line as clearly as I can. But it isn't the pink spot on your stomach.

The spot that sent me spiraling at midnight

Let me name what I did wrong first, because you might be doing it too. I took one small, local thing and let it stand in for every scary word I'd ever half-read about injectable drugs. The lump became a tumor. The redness became an allergy. By the time I'd finished my third tab I'd all but diagnosed myself with something requiring a hospital.

None of that was the reaction talking. That was 11 p.m. talking.

The reaction itself was doing something ordinary and knowable. So the rest of this is the map I didn't have that night: what a plain local spot is, the one whole-body scenario that's a genuine emergency, and why the redness and the lump and the bruise each show up. Then the smaller things — what you can do to see fewer of them, and the handful of signals that turn a "watch it" into a "call someone."

Most of the time, it's a local reaction — and it's uncommon

Start with the dull, reassuring name for what you're looking at: a local injection site reaction. Local is the word doing the work. It means the fuss stays where the needle went — a patch of redness, an itch, a bit of irritation, sometimes a small firm lump — and doesn't set anything off anywhere else.

Two things are worth knowing here. First, with semaglutide specifically, this isn't the common story. When researchers ran an early phase 2 trial of semaglutide — the one published in Diabetes Care back in 2016 — injection site reactions turned up in only a few cases. Not the headline. Not what most people on it wrestle with. So if you've been quietly assuming everyone's stomach looks like yours right now, they mostly don't.

Second, when it does happen, it tends to be short-lived. A local spot usually eases over a handful of days as the skin settles: the redness pales, the itch loses interest, the little lump softens and flattens. I won't hand you an exact number of days, because skin keeps its own schedule and I'd be inventing the figure. "A few days, trending better rather than worse" is the honest shape of it.

I'm careful with the word "harmless," because that's a promise I can't make for every bump on every person. Closer to the truth: a plain local reaction is usually benign and usually clears by itself. That's the reassuring middle — not "ignore it forever," just "this is a known, minor thing, and it's not the emergency your brain jumped to at midnight."

The clinical name — "injection site reaction" — sounds scarier than the thing itself. It mostly describes skin doing what skin does when you put a needle through it once a week: complaining locally, then getting over it.

The line that actually matters: one spot vs. your whole body

If you take one section with you, make it this one, because it's the line that separates "wait it out" from "stop and get help now."

A local reaction stays put. It's the red patch, the itch, the lump — all of it clustered at the injection site, and nowhere else. That's the entire point of the word local.

A serious hypersensitivity reaction is the opposite: it's your whole body answering at once. Hives spreading well beyond the injection spot. Swelling of the face, lips, tongue, or throat. A tight chest or trouble breathing. Sudden dizziness, or the plain sense that something is very wrong. Those are the signatures of anaphylaxis and angioedema, and both have been reported with semaglutide. They aren't common. But they are the reason this section exists.

The label doesn't hedge on what to do here. If a serious hypersensitivity reaction is suspected, the instruction is to stop the medication and seek medical attention promptly. Among the skin and injection-site reactions in this article, this is the one where "stop the drug" is the right move on its own — and even then it's not you improvising a dose decision, it's the label's own emergency instruction. Whole-body reaction, trouble breathing, swelling that reaches your face or throat: that's emergency services (911 in the US, or your local equivalent), not a browser tab.

Please don't file these two under the same heading. A pink spot on your stomach and a swelling throat are not two points on one spectrum — they're different categories. Treating them the same is how people either panic over a minor bump or, worse, sit too long on a real emergency.

The tell isn't how red the spot looks. It's whether the reaction stayed local or went whole-body. One spot: watch. Your whole body — hives, swelling, breathing — stop and get help.

Redness, a hard lump, a bruise: what each one is

Once you know it's local, it helps to know what each thing actually is, because "why is there a lump" is its own 2 a.m. rabbit hole.

Redness and itch. This is the mild one — a little local irritation where the needle and the medicine met the tissue. The skin flushes, maybe prickles or itches for a while, then loses interest. It's the most ordinary version of a local reaction.

The firm little lump. The clinical word is induration, which just means a small patch of hardened tissue. It tends to come from the tissue reacting to being injected: a little knot of irritation and absorption right under the skin. On its own it's usually benign, and it usually softens and fades over time as the area recovers. You can often feel it more than you can see it.

The bruise. This one usually isn't about the medicine at all — it's mechanical. When the needle goes in, it can nick one of the tiny blood vessels sitting under the skin, and a bit of blood leaks into the tissue. That's a bruise: the familiar bloom of purple-green that shows up, runs its color-wheel course, and clears. Benign, if a little annoying to look at.

None of this is unique to one pen. Injection site reactions are a general possibility with injectable GLP-1 medicines — semaglutide (sold as Wegovy for weight and Ozempic for type 2 diabetes) and tirzepatide (Zepbound and Mounjaro), which is a dual GIP/GLP-1 agonist with its own profile. The solid evidence I'm leaning on here is the semaglutide data, but the basic physics — needle, tissue, once a week — travels across the class.

What can turn it down: rotating sites and a few small habits

You can nudge the odds in your favor. Not erase them — nudge. I want to be straight about that ceiling: rotating sites and injecting well can lower how often you get a local reaction or a lump, but nothing here promises a spotless stomach forever.

The big one is rotation. Keep injecting the same square inch week after week and that patch of tissue never gets a break. Repeated irritation in one place is exactly where stubborn lumps like to set up shop. Moving the site around, spreading your weekly shots across the areas your clinician okayed instead of the same beloved spot, gives each patch time to recover. If you want the actual how-to on picking and cycling sites, that lives in our guide to self-injection technique and the piece on timing and rotating your weekly shot. I'm keeping this article on the skin, not the mechanics.

A couple of smaller habits people swear by. If your pen lives in the fridge, letting it come up closer to room temperature before you inject can take some sting out. Cold medicine going into warm tissue is more likely to bite. The exact temperature and how long it needs on the counter are on your product's leaflet, not a figure I'd invent here. And after the shot, resist the urge to rub the spot. A gentle press if you need it, but rubbing can aggravate the very tissue you're trying to be kind to.

The stuff I'm deliberately not covering here — needle angle, how to clean the site, exactly where on the body to inject — isn't an oversight. That's technique, and it belongs in the self-injection guide so this piece can stay on reading and managing the reaction once it shows up.

When a local spot still earns a call

Local usually means "watch, don't worry." But local isn't a free pass, and a few signals move a spot from the wait-and-see pile into the call-someone pile.

Get it looked at if:

• The lump keeps growing, or turns hard and genuinely painful rather than just noticeable.
• The redness spreads outward from the injection site, especially with warmth — and even more so if there's pus or a fever alongside it. Spreading redness plus heat plus fever is the classic picture of a possible skin infection, and that's a clinician's call, not a ride-it-out.
• The spot keeps getting worse after several days instead of better. A local reaction should be trending toward calm. One that's still worsening after several days instead of settling has earned a phone call.

What I'd steer you away from is the DIY dose fix: deciding on your own to cut your dose, skip a week, or quit because of a skin reaction. Dose changes are a conversation with whoever prescribes for you. (The exception is the whole-body hypersensitivity emergency from earlier — that's the label's own stop-now instruction, a different scenario from a skin reaction.) If the shots are rough on your stomach instead, that's a separate topic we cover in the nausea and stomach guide, and it's also worth a mention to your prescriber rather than a solo experiment.

A local spot that's fading by day 3 is doing exactly what it should. A spot that's redder, hotter, and spreading on day 4 is telling you something different. That's the one to call about.

Zoom out: the rest of the safety map, worst first

Skin reactions are why you're here. But on the drug's actual safety hierarchy they sit fairly low, and it helps to see the whole thing laid out so the routine stuff and the serious stuff don't blur together.

At the top is a hard stop. In the US, the semaglutide label carries a boxed warning — the FDA's most serious flag — tied to a risk of thyroid C-cell tumors seen in rodents. Alongside it sits a flat contraindication: a personal or family history of medullary thyroid carcinoma (MTC), or the inherited syndrome Multiple Endocrine Neoplasia type 2 (MEN 2). This isn't a weigh-the-pros-and-cons item. If that history runs in your family, the drug is off the table.

One rung down is a warning rather than a ban. Acute pancreatitis — inflammation of the pancreas — has been reported with GLP-1 medicines. The label's guidance is to stop the drug if pancreatitis is suspected. In plain language: severe, persistent belly pain, often boring through to the back, isn't a ride-it-out symptom. It's a get-checked-promptly one.

Then the everyday tier, the one most people run into: gastrointestinal stuff. Nausea, vomiting, diarrhea, and constipation — usually loudest early or just after a dose step-up, and generally the manageable background noise of being on one of these drugs rather than a warning sign.

Two footnotes on this map. First, the serious hypersensitivity reaction from earlier — anaphylaxis, angioedema — sits on its own axis, apart from these three tiers. It's rare, it's an emergency, and it doesn't slot neatly into "contraindication vs. warning vs. common." Keep it filed under its own heading. Second, "boxed warning" and "contraindication" are US FDA terms describing the US label. If you're reading from the UK, the EU, Canada, Australia, or elsewhere, your own regulator's wording, the approved indications, and even which brand sits on the pharmacy shelf can differ. The seriousness tiers travel well; the exact language is worth checking against your country's label. For the wider drug-safety picture, we keep a separate interactions and safety guide.

What to bring to your next visit

If you started this article poking at a lump and bracing for bad news, here's the short version to carry out. A red, itchy, faintly lumpy spot where you injected is, most of the time, a local reaction: uncommon on semaglutide to begin with, usually benign, and usually gone within a few days. The bruise is mechanical. The lump usually softens on its own. None of it is the emergency your midnight brain insisted it was.

The one scenario that is urgent is the whole-body one — hives everywhere, swelling of the face, lips, or throat, trouble breathing. That's a stop-and-get-help-now, not a wait-and-see. Between those two poles sits a small watch list: a lump that keeps growing, spreading redness with warmth or fever, a spot getting worse instead of better after several days.

So next time you're in front of whoever manages your prescription, a few things are worth raising: what your injection sites have been doing, whether that firm lump is worth an in-person look, and how they'd want you to handle a reaction that won't settle. Snap a photo of the spot on a good-light day if it helps — it turns "I think it looked kind of red?" into something a clinician can actually read.

Everything here comes from semaglutide's published clinical research and its approved US label, and none of it stands in for the person who knows your chart. What to keep injecting, what to lower, and when to worry are calls for your own doctor or pharmacist. But if you've been lying awake convinced the coin of pink on your stomach means something dire, the un-catastrophized answer is usually the true one: it's local, it's minor, and it's already on its way out.

Start managing your GLP-1 with Blueshot

AI coaching, injection scheduling, and weight tracking in one app